drugset / Trial / NCT00170378
The Use of Low Molecular Weight Heparin in Traumatic Brain Injury
Phase 4
Completed
300 enrolled
Hennepin Healthcare Research Institute
Aventis Pharmaceuticals · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
To study the safety and efficacy of early administration of Low Molecular Weight Heparin to patients with traumatic brain injury.
Timeline
- Start
- 2002-12
- Primary completion
- —
- Completion
- 2005-08
Publications
- Background Kim J, Gearhart MM, Zurick A, Zuccarello M, James L, Luchette FA. Preliminary report on the safety of heparin for deep venous thrombosis prophylaxis after severe head injury. J Trauma. 2002 Jul;53(1):38-42; discussion 43. doi: 10.1097/00005373-200207000-00008.
- Background Norwood SH, McAuley CE, Berne JD, Vallina VL, Kerns DB, Grahm TW, Short K, McLarty JW. Prospective evaluation of the safety of enoxaparin prophylaxis for venous thromboembolism in patients with intracranial hemorrhagic injuries. Arch Surg. 2002 Jun;137(6):696-701; discussion 701-2. doi: 10.1001/archsurg.137.6.696.
- Background Norwood SH, McAuley CE, Berne JD, Vallina VL, Kerns DB, Grahm TW, McLarty JW. A potentially expanded role for enoxaparin in preventing venous thromboembolism in high risk blunt trauma patients. J Am Coll Surg. 2001 Feb;192(2):161-7. doi: 10.1016/s1072-7515(00)00802-4.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enoxaparin sodium | Other / unclassified | — | — |